Furthermore, Gettinger et al. found that homozygous loss of B2M leads to the downregulation of MHC-I in cancer cells, further facilitating resistance to ICIs.24Figure 3 demonstrates how loss of B2M destabilizes the MHC-I. The gene discussed is B2M; the disease is cancer.